SCHEMBL5794680

SCHEMBL5794680

CCn1c2ccc(C)cc2c2cc(CO)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.55
HPGD P15428 5/20 0.55
ALDH1A1 P00352 5/20 0.55
HSD17B10 Q99714 2/20 0.55
TSHR P16473 2/20 0.55
MAPK1 P28482 2/20 0.51
LMNA P02545 2/20 0.51
POLB P06746 1/20 0.51
RORC P51449 2/20 0.48
PGR P06401 2/20 0.48
HTT P42858 4/20 0.44
MAPT P10636 8/20 0.42
TP53 P04637 4/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
HBB P68871 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RORA P35398 1/20 0.41
RORB Q92753 1/20 0.41
RPS6KA5 O75582 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163862 0.91 KDM4E (0.64) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL13067443 0.86 ALDH1A1 (0.54) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL1611235 0.86 KDM4E (0.52) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL4849333 0.83 KDM4E (0.67) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL25620763 0.83 KDM4E (0.53) KDM4EHPGDALDH1A1HSD17B10MAPK1
SCHEMBL5798005 0.82 PTGER4 (0.57) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL5797737 0.82 KDM4E (0.54) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL541218 0.80 PTGER4 (0.59) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL20315356 0.80 KDM4E (0.48) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL21093609 0.79 KDM4E (0.46) KDM4EHPGDALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006012310-A2 CARBAZOLE DERIVATIVES FOR TREATING POLYCYSTIC KIDNEY DISEASE GENZYME CORPORATION (US) 2006-02-02 WO disclosed